Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ALG 125755

Next Previous
Drug Profile

ALG 125755

Alternative Names: ALG-125755

Latest Information Update: 03 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Aligos Therapeutics
  • Class Antivirals; Oligonucleotides; Small interfering RNA
  • Mechanism of Action Hepatitis B surface antigen expression inhibitors; RNA interference
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Hepatitis B

Most Recent Events

  • 31 Dec 2024 ALG 125755 is available for licensing as of 31 Dec 2024. https://aligos.com/
  • 31 Dec 2024 Suspended - Phase-I for Hepatitis B (In the elderly, In volunteers, In adults) in New Zealand, Moldova, Bulgaria, Bulgaria, Romania (SC) prior to December 2024
  • 21 Jun 2023 Updated adverse events data from a phase I trial in Hepatitis B presented at the European Association for the Study of the Liver Congress 2023 (EASL-2023)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top